FDA.reportPublic FDA data

Roweepra 250 MG Oral Tablet

RxCUI
1875868
RxNorm name
Roweepra 250 MG Oral Tablet
Display name
Roweepra 250 MG Oral Tablet
Full name
Roweepra 250 MG Oral Tablet
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:25

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
LevetiracetamLEVETIRACETAMOWP Pharmaceuticals, Inc.e662bf5b-c81c-4bcd-ba2e-552df95ca6f92025-05-15Warnings, Adverse reactionsExact identifier
rxcui: 1875868

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
e662bf5b-c81c-4bcd-ba2e-552df95ca6f9Roweepra 250 MG Oral Tablet [PSN] · levetiracetam 250 MG Oral Tablet [Roweepra] [SBD] · Roweepra 250 MG Oral Tablet [SY]35These highlights do not include all the information needed to use ROWEEPRA (levetiracetam) TABLETS safely and effectively. See full prescribing information for ROWEEPRA TABLETS. ROWEEPRA (levetiracetam) tablets, for oral use Initial U.S. Approval: 199920250515